JEADVObservational studyLetter
Baricitinib versus ritlecitinib for severe alopecia areata
A 24-week real-world study.
Cedirian S, Martelli G, Pampaloni F, Rapparini L, Quadrelli F, Bruni F, Ala L, Bortone G, Acri MC, Rossi A, Pellacani G, Lacarrubba F, Dall'Oglio F, Micali G, Foggia L, Cantelli M, D'Elia C, Nappa P, Diluvio L, Matteini E, Bianchi L, Naldi L, Bolzon A, Peris K, Caldarola G, Pinto LM, Girolomoni G, Marangoni F, Bellinato F, Gisondi P, Silvi G, Prignano F, Pimpinelli N, Tomasini C, Barruscotti S, Simonetti O, De Simoni E, Ambrogio F, Foti C, Boccaletti V, Romanò C, Fraghì A, Marzano AV, Mattioli MA, Ferrucci S, Sechi A, Valtellini L, Barbareschi M, Gallo G, Ortoncelli M, Ribero S, Quaglino P, Di Corteranzo IG, Balestri R, Pagliarello C, Caro RDC, Zalaudek I, Vagnozzi E, Fargnoli MC, Caponio C, Rubegni P, Cinotti E, Trovato E, Romanelli M, Dini V, Margiotta FM, Feliciani C, Satolli F, Del Giudice MBF, Atzori L, Sanna S, Lembo S, Raimondo A, Magnano M, Argenziano G, Babino G, Fulgione E, Balato A, Rongioletti F, Pesce N, Guida S, Bigotto GD, Guglielmo A, Schettini N, Borghi A, Gargiulo L, Vignoli C, Narcisi A, Pezzolo E, Caroppo F, Fortina AB, Megna A, Filippeschi C, Oranges T, Tronconi G, Patrignani A, Piraccini BM, Starace M
Journal of the European Academy of Dermatology and VenereologyIn the feed 31 Aug 2026, published online 31 Aug 2026, issue 2026 Aug 31, added to PubMed 31 Aug 2026
Topics: HairChildrenJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42670280 · DOI 10.1111/jdv.70698